• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Dengue detection and serotyping using multiplex real time polymerase chain reaction: Study from a tertiary care centre in Eastern India

    Dr. Manish Ranjan, Dr. Shveta, Dr. Sakshi Kawatra, Dr. Saumya Singh, Dr. Abhishek Agrawal, Dr. Anupama Sharma

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 1475-1481

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Dengue is an arboviral infection transmitted through the bite of Aedes mosquitoes having four distinct serotypes DENV 1-4. Secondary infections often lead to increased disease severity. The study was carried out with an aim to analyze dominant serotype in circulation and to find an association between serotype and hematological parameters.
Material & Methods: A total of 163 Dengue Positive samples were subjected to serotype-specific Real-time Polymerase chain reaction to identify the serotype. Hematological parameters viz; WBC counts, Hematocrit value, platelets, lymphocyte % were also studied concurrently for these patients.
Results: The mean age of the participants was 27.2 years with male preponderance.NS1 antigen positive (74.8%), IgM (38%) and both NS1 & IgM positives (12.8%) were detected. The predominant serotype identified was DENV-2(48.4%), DENV-4(43.5%), and DENV-3 (7.9%). Statistically significant difference in platelet counts was observed in DENV-2 & DENV-4.White blood cell counts showed statistically significant differences within DENV-2 and DENV-3 serotypes.
Conclusion: Cocirculation of multiple serotypes of DENV was observed in our study. The application of molecular testing will increase DENV diagnostics, especially in secondary infections which carry more chances of adverse outcomes. We recommend the inclusion of serotype testing in the Dengue diagnostic algorithm to be able to reduce morbidity and mortality.
Keywords:
    Dengue Virus serotyping real-time reverse transcriptase polymerase chain reaction Thrombocytopenia antibody dependent enhancement
  • PDF (516 K)
  • XML
(2022). Dengue detection and serotyping using multiplex real time polymerase chain reaction: Study from a tertiary care centre in Eastern India. European Journal of Molecular & Clinical Medicine, 9(2), 1475-1481.
Dr. Manish Ranjan, Dr. Shveta, Dr. Sakshi Kawatra, Dr. Saumya Singh, Dr. Abhishek Agrawal, Dr. Anupama Sharma. "Dengue detection and serotyping using multiplex real time polymerase chain reaction: Study from a tertiary care centre in Eastern India". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 1475-1481.
(2022). 'Dengue detection and serotyping using multiplex real time polymerase chain reaction: Study from a tertiary care centre in Eastern India', European Journal of Molecular & Clinical Medicine, 9(2), pp. 1475-1481.
Dengue detection and serotyping using multiplex real time polymerase chain reaction: Study from a tertiary care centre in Eastern India. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 1475-1481.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 114
  • PDF Download: 151
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus